Sign up


Match Document Document Title
8388992 Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay  
A disposable paper towel with an anti-microbial lotion and is provided with a chromatic transfer indicator which undergoes a delayed, visually perceptible color change at a predetermined time after...
8388984 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules  
Compositions which deliver adsorbents, alone or in combination with active drug “degrading molecules,” in a site-specific manner to the intestine, and which eliminate or at least lower the con...
8388982 Photo-induced damage mitigating agents and preparation and methods of use thereof  
Compositions, devices, systems and methods for reducing and/or preventing photo-induced damage of one or more reactants in an illuminated analytical reaction by addition of one or more...
8389005 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance  
Alterations of redox homeostasis in mammals underlie a host of symptoms, syndromes and diseases, including AIDS and cancer, which can be successfully treated by administration to a mammal of...
8388983 Film coatings containing fine particle size detackifiers and substrates coated therewith  
The present invention is directed to film coating compositions for use on oral dosage forms such as compressed tablets and other orally-ingestible substrates which contain a fine particle size...
8388985 Easily dispersible lipidic phase  
The present invention relates to the use of a lipidic phase comprising an oil and a lipophilic additive (LPA), which is suitable to make an oil-in-water emulsion by application of low energy or a...
8389768 Methods and compositions comprising novel cationic lipids  
Provided herein are novel cationic lipids, compositions comprising the cationic lipids, and methods of using the cationic lipids. In some claims, the cationic lipids have cytotoxic activity and can...
8388997 Method of preparing an unsaturated fatty acid dry concentrate  
There is provided a method of preparing an unsaturated fatty acid dry concentrate, wherein a substance comprising at least one unsaturated fatty acid is applied on a biologically inert matrix...
8383090 Cleansing composition based on oily substances  
A cleansing composition based on oily substances, particularly for cleansing skin and/or hair and having excellent dermatological properties, is described. The composition is characterized in that...
8383136 Micelle encapsulation of therapeutic agents  
The invention provides active agents, such as paclitaxel, rapamycin, or 17-AAG, encapsulated by safe poly(ethylene glycol)-block-poly(lactic acid) (“PEG-b-PLA”) micelles. The compositions pro...
8383135 Solid dosage form that promotes reliable oral, esophageal and GI transit  
A solid dosage form designed to facilitate rapid and reliable oral, esophageal and GI transit has a surface area of the contact patch, i.e., the area of contact between the dosage form and the...
8383134 Biodegradable material based on opened starch  
The present application relates to a biodegradable material comprising opened starch or a mixture of opened starch and destructurised starch. The biodegradable material comprises about 50 to about...
8377457 Naturally derived glyceryl dimer polyesters having liquid and solid domains  
The present invention is directed to a series of polymeric glyceryl esters that have two different molecular weight ester chains, one solid and one liquid, which when combined into a single...
8377454 Treating male infertility secondary to sperm oxidative stress  
A profertility composition for administration to infertile men with sperm oxidative stress is disclosed. The composition comprises a unique combination of a pharmaceutically acceptable vitamin E,...
8377453 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic  
Compositions and methods for the treatment of pain in a mammal are described. More specifically, a dosage form designed for release of acetaminophen and an opioid is described, wherein the dosage...
8377456 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives  
The present specification discloses tetrahydroindolone derivatives or analogues and methods for treating cognitive/attention deficit disorders using such tetrahydroindolone derivatives and analogues.
8377420 Injectable void filler for soft tissue augmentation  
The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present...
8377455 Biosurfactant composition produced by a new Bacillus licheniforms strain, uses and products thereof  
New Bacillus licheniformis strain named V9T14 that produces a new biosurfactant composition that is effective against colonization and/or bio film formation from bacteria. The new biosurfactant...
8372821 Stable aqueous compositions comprising bioactive creatine species  
Compositions containing one or more bioactive forms of creatine which are aqueous compositions in which the one or more bioactive forms of creatine do not appreciably degrade into creatinine. Also...
8372415 Wet granulation using a water sequestering agent  
Disclosed are tablets comprising hydrolytically stable formulations of (6-(5-fluoro-2-(3,4,5...
8372441 Materials and methods for preparation of alkaline earth ferrates from alkaline earth oxides, peroxides, and nitrates  
The subject invention concerns methods for preparing alkaline earth ferrates and the preparation of hemostatic compositions from alkaline earth ferrates. In one embodiment, the alkaline earth...
8372423 Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same  
This disclosure provides implantable devices coated with microporous surface layers with macrotopographic features that improve bio-integration at the interface of the implantable devices and the...
8372414 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications  
The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one...
8367568 Wet wipes having a liquid wipe composition with an organopolysiloxane  
The present disclosure generally relates to wet wipes having liquid wipe compositions that including an organopolysiloxane that reduces sheet-to-sheet adhesion, improves the stack height, increases...
8367078 Kinase inhibitor compounds  
The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating disorders,...
8367044 Sunscreen cosmetic  
The present invention provides a sunscreen cosmetic comprising, relative to the total amount of the sunscreen cosmetic, 10-90 wt % of agar microgel (wherein the agar content in the agar microgel is...
8367081 Macrocyclic lactone compounds and methods for their use  
A method of inhibiting smooth muscle cell proliferation or cytokine production in a subject, comprising administering a compound disclosed herein to the subject, is provided. The compound can be...
8367080 Pharmaceutical formulation for use in HIV therapy  
The invention discloses a formulation prepared by granulating at least one anti-retro viral drug and at least one pharmaceutically acceptable additive, using an organic solvent; milling the...
8367079 Liquid preservative compositions  
A liquid preservative composition comprises (a) an alkanol fatty monoester; and (b) an aqueous isothiazolinone solution, an alkanol-substituted aromatic compound, or a combination thereof; and is...
8361272 Polyurethane elastomers  
A linear polymer is obtained by reacting together a polyethylene glycol or polypropylene glycol; a PEG-PPG-PEG or PPG-PEG-PPG block copolymer; a difunctional amine or diol; and a diisocyanate. A...
8361484 Polymer systems for lung volume reduction therapy  
One aspect of the invention relates to a hydrogel comprising a polymer comprising a plurality of pendent hydroxyl groups, a crosslinker, and a sclerosing agent. Another aspect of the invention...
8361273 Polyurethane elastomers  
This disclosure relates to a linear polymer obtained by reacting a polyethylene glycol, a polypropylene glycol; a diol; and a diisocyanate, as well as a controlled release composition containing...
8361497 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same  
A multi-compartment capsule, comprising, a first receiving chamber comprising at least one ingredient having a first physical state, wherein said ingredient is selected from the group consisting of...
8362085 Method for administering an NMDA receptor antagonist to a subject  
The invention provides methods for administering memantine to a subject. Memantine in an extended release form containing 22.5 to 30 mg memantine or a pharmaceutically acceptable salt is...
8357379 High concentration baclofen preparations  
Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for...
8357377 Cyclodextrin-based materials, compositions and uses related thereto  
This application discloses cyclodextrin-modified materials for carrying drugs and other active agents, such as nucleic acids. Compositions are also disclosed of cyclodextrin-modified materials that...
8357380 Coenzyme Q10-containing composition  
The coenzyme Q10-containing liquid composition is obtained by dispersing and emulsifying coenzyme Q10 in an aqueous liquid containing a water-soluble substance consisting of octenylsuccinate starch...
8357378 Fragmented polymeric compositions and methods for their use  
Cross-linked hydrogels comprise a variety of biologic and non-biologic polymers, such as proteins, polysaccharides, and synthetic polymers. Such hydrogels preferably have no free aqueous phase and...
8357399 Tamper-resistant oral opioid agonist formulations  
Disclosed is an oral dosage form comprising: (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is not released when the dosage form is administered orally intact.
8354116 Bifunctional synthetic molecules  
The synthesis and use of bifunctional molecules to improve the topical and transdermal delivery efficiency of various types of therapeutic agents or agents designed to promote the transdermal...
8354466 Method for formulating agrochemical active ingredients so as to regulate their release kinetics, protect them from outside stresses, and keep their users safe  
The invention pertains to a new method for formulating any agrochemical active ingredient so as to protect the user, protect this active ingredient from outside stresses, and control its release...
8354117 Preparation for oral cavity  
Object of the present invention is to provide a preparation for oral cavity that is appropriately usable as a prophylactic agent for dental caries, a therapeutic agent for dental caries at early...
8353399 Preparation-at-use device comprising pre-formed hydrogel product  
Disclosed is a preparation-at-use device comprising: (1) a pre-formed hydrogel component packaged in a first compartment; the pre-formed hydrogel component comprising a gelling agent and a solvent;...
8349882 Pharmaceutical composition for external use  
A pharmaceutical composition for external use, including: i) luliconazole represented by the following structural formula (1) and/or a salt thereof; and ii) one or two or more selected from...
8349348 Biocompatible phase invertible proteinaceous compositions and methods for making and using the same  
Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a proteinaceous...
8343942 Methods for treating interstitial cystitis  
Described herein are methods for treating interstitial cystitis in a subject comprising administering to the subject an effective amount of a compound which is a modified hyaluronan or a...
8343513 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions  
Polymer and drug containing compositions and method of preparing such compositions are disclosed. The dispersed phase formulation has a polymer, a pharmaceutically or biologically active agent and...
8343518 Preservation of bioactive materials by freeze dried foam  
This invention provides methods and compositions to preserve bioactive materials in a dried foam matrix. Methods provide non-boiling foam generation and penetration of preservative agents at...
8343514 Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis  
The invention is related to a sol-gel nanostructured titania reservoir and its synthesis which is biocompatible with brain tissue. The pore size distribution, crystallite size and the extent of the...
8343543 Lipase inhibiting composition  
Pharmaceutical compositions that contain a lipase inhibitor having a melting point ≧37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, an...